Sanofi
SAN
Real-time Euronext Paris - 07/19 05:35:05 pm
72.11EUR
-0.55%
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Sales35 05535 048
EBITDA-10 967
Operating profit (EBIT)8 3998 298
Pre-Tax Profit (EBT)5 5306 312
Net income8 4345 080
EPS ( € )6,714,16
Dividend per Share ( € )3,033,01
Yield4,22%4,15%
Announcement Date02/07/2018
06:36am
-
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 20172018
Debt5 28615 904
Finance--
Operating income (EBITDA)-10 967
Leverage
(Debt/EBITDA)
-1,45x
Capital Expenditure-2 241
Book Value Per Share (BVPS)46,5 €46,9 €
Cash Flow per Share-6,21 €
Announcement Date02/07/2018
06:36am
-
Balance Sheet Analysis
Financial Ratios
Size 2018e 2019e
Capitalization 90 118 M€ -
Entreprise Value (EV) 106 022 M€ 103 862 M€
Valuation 2018e 2019e
P/E ratio (Price / EPS) 17,4x 16,3x
Capitalization / Revenue 2,57x 2,48x
EV / Revenue 3,03x 2,86x
EV / EBITDA 9,67x 8,94x
Yield (DPS / Price) 4,15% 4,35%
Price to book (Price / BVPS) 1,54x 1,51x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) 23,7% 24,5%
operating Leverage (Delta EBIT / Delta Sales) # 1,94x
Net Margin (Net Profit / Revenue) 14,5% 15,0%
ROA (Net Profit / Asset) 6,07% 6,47%
ROE (Net Profit / Equities) 11,1% 12,0%
Rate of Dividend 72,2% 70,9%
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   6,40% 4,24%
Cash Flow / Sales 22,2% 23,4%
Capital Intensity (Assets / Sales) 2,39x 2,31x
Financial Leverage (Net Debt / EBITDA) 1,45x 1,18x
Price Earning Ratio
BNA & Dividende